JP2024537250A5 - - Google Patents

Info

Publication number
JP2024537250A5
JP2024537250A5 JP2024521254A JP2024521254A JP2024537250A5 JP 2024537250 A5 JP2024537250 A5 JP 2024537250A5 JP 2024521254 A JP2024521254 A JP 2024521254A JP 2024521254 A JP2024521254 A JP 2024521254A JP 2024537250 A5 JP2024537250 A5 JP 2024537250A5
Authority
JP
Japan
Prior art keywords
amino acid
seq
sequence
acid sequence
flu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024521254A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024537250A (ja
Filing date
Publication date
Priority claimed from GBGB2114328.4A external-priority patent/GB202114328D0/en
Priority claimed from GBGB2208070.9A external-priority patent/GB202208070D0/en
Priority claimed from GBGB2213958.8A external-priority patent/GB202213958D0/en
Application filed filed Critical
Priority claimed from PCT/GB2022/052534 external-priority patent/WO2023057766A1/en
Publication of JP2024537250A publication Critical patent/JP2024537250A/ja
Publication of JP2024537250A5 publication Critical patent/JP2024537250A5/ja
Pending legal-status Critical Current

Links

JP2024521254A 2021-10-06 2022-10-06 インフルエンザワクチン Pending JP2024537250A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB2114328.4A GB202114328D0 (en) 2021-10-06 2021-10-06 Influenza vaccines
GB2114328.4 2021-10-06
GB2208070.9 2022-05-31
GBGB2208070.9A GB202208070D0 (en) 2022-05-31 2022-05-31 Influenza vaccines
GB2213958.8 2022-09-23
GBGB2213958.8A GB202213958D0 (en) 2022-09-23 2022-09-23 Influenza vaccines
PCT/GB2022/052534 WO2023057766A1 (en) 2021-10-06 2022-10-06 Influenza vaccines

Publications (2)

Publication Number Publication Date
JP2024537250A JP2024537250A (ja) 2024-10-10
JP2024537250A5 true JP2024537250A5 (https=) 2025-10-15

Family

ID=83692952

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024521254A Pending JP2024537250A (ja) 2021-10-06 2022-10-06 インフルエンザワクチン

Country Status (6)

Country Link
US (1) US20240408190A1 (https=)
EP (1) EP4412644A1 (https=)
JP (1) JP2024537250A (https=)
AU (1) AU2022360009A1 (https=)
CA (1) CA3234653A1 (https=)
WO (1) WO2023057766A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202004825D0 (en) * 2020-04-01 2020-05-13 Diosynvax Ltd Influenza vaccines
GB202315888D0 (en) * 2023-10-17 2023-11-29 Diosynvax Ltd Influenza vaccines
WO2026018213A1 (en) * 2024-07-18 2026-01-22 Vaxthera Sas A broadly protective mosaic vaccine against highly pathogenic avian influenza viruses
WO2026074282A1 (en) * 2024-10-01 2026-04-09 Diosynvax Ltd. Influenza vaccines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR083533A1 (es) * 2010-10-22 2013-03-06 Boehringer Ingelheim Vetmed Proteinas de hemaglutinina 5 (h5) para el tratamiento y prevencion de las infecciones de gripe
CN103221064B (zh) * 2011-11-23 2014-12-03 苏州工业园区唯可达生物科技有限公司 抗流感病毒的免疫方法及其组合疫苗
CA2863949C (en) * 2012-02-13 2021-06-29 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Computationally optimized broadly reactive antigens for human and avian h5n1 influenza
EP4011451A1 (en) 2015-10-22 2022-06-15 ModernaTX, Inc. Metapneumovirus mrna vaccines
WO2020061443A2 (en) * 2018-09-21 2020-03-26 Board Of Regents Of The University Of Nebraska Methods of making and using universal centralized influenza vaccine genes

Similar Documents

Publication Publication Date Title
JP2024537250A5 (https=)
US11229694B2 (en) Vaccine against RSV
JP2023018073A5 (https=)
US20230340031A1 (en) Self-assembling protein nanoparticles with built-in six-helix bundle proteins
JP2025184979A5 (https=)
JP2023522154A5 (https=)
JP2022513326A5 (https=)
JP2020530765A5 (https=)
AU2018351209B2 (en) Mutant of H3N2 subtype influenza virus hemagglutinin protein and use thereof
EA039124B1 (ru) Стабилизированные f-белки rsv до слияния
KR20220057578A (ko) 인플루엔자 바이러스 백신 및 이의 용도
US10548973B2 (en) Polypeptide carrier for presenting target polypeptide and uses thereof
JP2020509770A5 (https=)
CA3053591C (en) Polypeptide carrier for presenting target polypeptide and uses thereof
CN114409803B (zh) 流感病毒三聚体亚单位疫苗及其应用
JP2024539609A5 (https=)
WO2018175560A1 (en) Nanoparticle immunogens to elicit responses against the influenza receptor binding site on the hemagglutinin head domain
JP6373601B2 (ja) アカバネウイルスに対して中和活性を有する抗体を誘導するペプチド
JP2024534178A5 (https=)
JP2024523329A5 (https=)
US12109261B1 (en) Stabilized hemagglutinin (HA) trimers as influenza vaccine antigens
CN115197303B (zh) 一种s蛋白的受体结合结构域的突变体及其应用
CN118725052A (zh) 具有稳定融合前构象的呼吸道合胞病毒f蛋白
OA21734A (en) Influenza virus-based isolated recombinant virus.
JPWO2005090576A1 (ja) 百日咳感染症予防用ｄｎａ構築物